AMY MCGUIRE to Health Policy
This is a "connection" page, showing publications AMY MCGUIRE has written about Health Policy.
Connection Strength
2.714
-
Health system sustainability and resilience: a preliminary provision of measurement through a "mash-up" index. Health Econ Policy Law. 2025 Jul; 20(3):313-325.
Score: 0.789
-
Clinical integration of next generation sequencing: a policy analysis. J Law Med Ethics. 2014; 42 Suppl 1:5-8.
Score: 0.353
-
Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Annu Rev Med. 2012; 63:23-33.
Score: 0.300
-
Currents in contemporary ethics. Direct-to-consumer genetic testing: is it the practice of medicine? J Law Med Ethics. 2009; 37(2):369-74.
Score: 0.249
-
An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA. 2008 Dec 10; 300(22):2669-71.
Score: 0.248
-
Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider. Genet Med. 2008 Jul; 10(7):495-9.
Score: 0.241
-
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement. JAMA Netw Open. 2024 06 03; 7(6):e2414650.
Score: 0.182
-
Legal Barriers to Adolescent Participation in Research About HIV and Other Sexually Transmitted Infections. Am J Public Health. 2016 Jan; 106(1):40-4.
Score: 0.100
-
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol. 2013 Nov; 11(11):e1001699.
Score: 0.087
-
Science and regulation. Regulating direct-to-consumer personal genome testing. Science. 2010 Oct 08; 330(6001):181-2.
Score: 0.070
-
Identifiability of DNA data: the need for consistent federal policy. Am J Bioeth. 2008 Oct; 8(10):75-6.
Score: 0.061
-
Ventilator Triage Policies During the COVID-19 Pandemic at U.S. Hospitals Associated With Members of the Association of Bioethics Program Directors. Ann Intern Med. 2020 08 04; 173(3):188-194.
Score: 0.034